Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
0%
1 month
-9.09%
YTD
-4.81%
1 year
-2.55%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
29 November 24 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
25 November 24 |
5-Year Cervical Cancer Screening Progam Launched in Vietnam
×
5-Year Cervical Cancer Screening Progam Launched in Vietnam |
12 November 24 |
TruScreen Key Markets Update
×
TruScreen Key Markets Update |
11 November 24 |
Germany's Springer Nature Journal Publication on Truscreen
×
Germany's Springer Nature Journal Publication on Truscreen |
29 October 24 |
Ranked in Top 6 Global Women's Health Startups 2024 Report
×
Ranked in Top 6 Global Women's Health Startups 2024 Report |
03 October 24 |
TruScreen Featured in UNITAID Technology Landscape Report
×
TruScreen Featured in UNITAID Technology Landscape Report |
23 September 24 |
Dr Dexter Cheung Appointed Chair of Technology Committee
×
Dr Dexter Cheung Appointed Chair of Technology Committee |
03 September 24 |
Annual Shareholder Meeting Presentation
×
Annual Shareholder Meeting Presentation |
03 September 24 |
Results of Meeting
×
Results of Meeting |
16 August 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
05 August 24 |
Shareholder Meeting and Director Nomination Dates
×
Shareholder Meeting and Director Nomination Dates |
05 August 24 |
Truscreen Outperforms Pap Smear in Saudi Arabia Study
×
Truscreen Outperforms Pap Smear in Saudi Arabia Study |
24 July 24 |
Details of Company Address
×
Details of Company Address |
08 July 24 |
Truscreen Commences Major Commercial Rollout in Vietnam
×
Truscreen Commences Major Commercial Rollout in Vietnam |
05 July 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 May 24 |
Preliminary Final Results
×
Preliminary Final Results |
20 May 24 |
TruScreen Key Markets Update
×
TruScreen Key Markets Update |
27 March 24 |
TruScreen Presentation ASX Small and Mid-Cap Conference
×
TruScreen Presentation ASX Small and Mid-Cap Conference |
22 March 24 |
Change of Directors Interest Notice X 3
×
Change of Directors Interest Notice X 3 |
20 March 24 |
Appendix 2A
×
Appendix 2A |
18 March 24 |
Results of Placement and Rights Offer
×
Results of Placement and Rights Offer |
13 March 24 |
Truscreen Raises Additional NZ$520,000 in Share Placement
×
Truscreen Raises Additional NZ$520,000 in Share Placement |
08 March 24 |
TruScreen Market Access Developments - Indonesia and Kenya
×
TruScreen Market Access Developments - Indonesia and Kenya |
04 March 24 |
Truscreen Raises NZ$500,000 in Share Placement
×
Truscreen Raises NZ$500,000 in Share Placement |
28 February 24 |
Investor Presentation Update
×
Investor Presentation Update |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.